DOV vs PAHC · P/E 27, rev $4.24B vs P/E 13, rev $1.52B
Dover Corporation (DOV) versus Phibro Animal Health Corporation (PAHC) — a side-by-side from cached financials, not a winner call.
Dover Corporation (DOV) is a specialty industrial machinery company listed on US.
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported DOV revenue for 2026-06-30 was $4.24B. Net income was $550.7M. DOV currently screens at market cap $28.92B and trailing P/E 26.8.
Latest reported PAHC revenue for 2026-06-30 was $1.52B. Net income was $99.7M. Revenue was up 17.1% from 2025-06-30 to 2026-06-30. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
DOV currently screens at market cap $28.92B and trailing P/E 26.8. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
Not investment advice. Open the DOV and PAHC stock pages for the full models.
Not investment advice.